[1]
“LINICAL, SUBCLINICAL FEATURES AND TREATMENT OUTCOMES OF PATIENTS WITH TALAROMYCES MARNEFFEI INFECTION AT THE NATIONAL ”, YHCĐ, vol. 67, no. 6, June 2026, doi: 10.52163/yhc.v67i6.5545.